Graematter, Inc.

Graematter has developed and patented an FDA-related Regulatory Intelligence System.

  • Stage Full Product Ready
  • Industry IT Services
  • Location St. Louis, MO, USA
  • Currency USD
  • Employees 6
  • Website graematter.com

Company Summary

Graematter has created a proprietary information analytics system that consolidates information from numerous FDA sources into a single database with unique search capabilities. The system helps assure that regulatory staffs will find the critical information needed to develop the shortest, lowest cost pathway to FDA approval. In addition, the Graematter System typically reduces the search time from a week to less than two hours.

Team

  • Merle Symes
    CEO

    - President & CEO Ulrich Medical (spine implants)
    - President & CEO, Provenance Group (consultant and equity partner in early stage ventures)
    - VP External Technology – Bausch & Lomb
    MBA – Wharton
    BS –Chemical Engineering

  • Melissa Walker
    President/CTO and Founder

    - Sr. VP Regulatory, Quality, & Compliance – Stereotaxis, Inc.
    - Exec Director, Global Regulatory Affairs – Bausch & Lomb
    - Adjunct Professor – Washington University
    - Fellow – Regulatory Affairs Professionals Society
    MS Zoology, BS Biology & Animal Science – East Texas State University

  • Peggy Stohr
    CFO

    - CFO EndoStim and Pulse Therapeutics
    - CFO Yurbuds
    - VP Administration & Controller – Stereotaxis, Inc.
    CPA
    MBA – Washington University MS & BS – Accounting

Advisors

  • Andrew Hoyne - Polsinelli
    Lawyer
    Unconfirmed
    Stone Carlie
    Accountant
    Unconfirmed

Previous Investors

  • BioGenerator
    Unconfirmed
    Missouri Technology Corporation
    Unconfirmed
    St. Louis County Helix Fund
    Unconfirmed

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free